TWI464267B - Cell marker and method for making the same - Google Patents

Cell marker and method for making the same Download PDF

Info

Publication number
TWI464267B
TWI464267B TW101106151A TW101106151A TWI464267B TW I464267 B TWI464267 B TW I464267B TW 101106151 A TW101106151 A TW 101106151A TW 101106151 A TW101106151 A TW 101106151A TW I464267 B TWI464267 B TW I464267B
Authority
TW
Taiwan
Prior art keywords
nano
cell
target material
diamond
nanocomposite
Prior art date
Application number
TW101106151A
Other languages
Chinese (zh)
Other versions
TW201335374A (en
Inventor
Liang Chien Cheng
Tsung Ching Lai
Ru Shi Liu
Michael Hsiao
Li Jane Her
Original Assignee
Taiwan Hopax Chems Mfg Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiwan Hopax Chems Mfg Co Ltd filed Critical Taiwan Hopax Chems Mfg Co Ltd
Priority to TW101106151A priority Critical patent/TWI464267B/en
Publication of TW201335374A publication Critical patent/TW201335374A/en
Application granted granted Critical
Publication of TWI464267B publication Critical patent/TWI464267B/en

Links

Description

細胞標定物及其製造方法Cell marker and method of producing the same

本發明係關於一種細胞標定物及其製造方法,特別係關於一種長效型之細胞標定物及其製造方法。The present invention relates to a cell calibrator and a method of producing the same, and more particularly to a long-acting cell calibrator and a method of producing the same.

癌細胞之生成皆來自正常細胞之不正常之增生。大體而言,正常細胞受人體內基因之控制,不斷地進行增殖、分化、成長、老死的過程。在增殖之過程,部分之正常細胞由於內在因素之改變,如基因突變,或是外在因素之影響,如有毒致癌物,病毒感染等,而脫離正常之細胞分化程序,使得細胞不正常地增生。細胞不正常的增生現象最初可藉由身體之免疫系統所認出,將之消滅,或是身體內部自行啟動凋零基因,而導致癌細胞自然地死亡。然而,當此不正常現象超過防禦機制的負荷時,癌細胞將完全脫離身體之控制,且進一步無限制地增生,不正常增生之細胞就會演變為腫瘤。當身體內部形成腫瘤後,必須藉由化學方式或物理方式以去除或治療之。在治療其前後,肉眼無法觀測之癌細胞必須利用標定之方式以確認癌細胞之生長位置,再佐以化學治療以徹底根除癌細胞之源頭,並降低癌症復發之機率。The formation of cancer cells comes from the abnormal proliferation of normal cells. In general, normal cells are controlled by genes in the human body, constantly undergoing processes of proliferation, differentiation, growth, and death. During the process of proliferation, some normal cells are abnormally affected by changes in internal factors such as genetic mutations or external factors such as toxic carcinogens, viral infections, etc., and the normal cell differentiation process. . Abnormal proliferation of cells can be initially recognized by the body's immune system, or eliminated, or the body's internal activation of the withering genes, resulting in cancer cells naturally die. However, when this abnormality exceeds the load of the defense mechanism, the cancer cells will be completely out of the body's control, and further unrestricted hyperplasia, and the abnormally proliferating cells will evolve into tumors. When a tumor is formed inside the body, it must be removed or treated by chemical or physical means. Before and after treatment, cancer cells that are invisible to the naked eye must use calibration to confirm the growth of cancer cells, and then use chemotherapy to completely eradicate the source of cancer cells and reduce the chance of cancer recurrence.

長期以來,有機染料係較常見之用來標記生物體之大分子、各種蛋白間之交互作用亦或是作為標訂癌細胞之材料。然,有機染料尚具下述缺點:(1)低光穩定性;(2)較窄之激發譜;及(3)螢光壽命短暫等條件,限制其於生物分子、細胞體內、生物體內成像之應用。由於癌細胞需長期追蹤與標記,故尋找一種具長效型標記物應用於細胞內部之材料為科學家長期研究之目標。For a long time, organic dyes have been used to label macromolecules of organisms, interactions between various proteins, or as materials for labeling cancer cells. However, organic dyes have the following disadvantages: (1) low light stability; (2) narrow excitation spectrum; and (3) short fluorescence lifetime conditions, limiting their imaging in biomolecules, cells, and in vivo. Application. Since cancer cells need long-term tracking and labeling, it is a long-term research goal of scientists to find a material with long-acting markers applied to the interior of cells.

綜上所述,有鑒於長效型標記物於癌症治療上之極大潛力,改進有機染料之缺點,自然成為產業上急需突破的重點,因此,發展一種具長效型細胞標定之螢光材料實有其必要。In summary, in view of the great potential of long-acting markers in cancer treatment, improving the shortcomings of organic dyes has naturally become an urgent need for breakthroughs in the industry. Therefore, the development of a fluorescent material with long-acting cell calibration It is necessary.

有鑒於此,本發明目的之一即是開發一種具良好光學性質之奈米複合材料,而該奈米複合材料係可應用於細胞標定上。In view of this, one of the objects of the present invention is to develop a nanocomposite having good optical properties, and the nanocomposite can be applied to cell calibration.

本發明之另一目的係開發一種適合用於長期追蹤體內癌細胞之奈米材料及其製造方法。該奈米材料係具有優異的生物相容性,且具有較傳統之有機螢光劑更佳之光學穩定性,而更適合應用於人體上。Another object of the present invention is to develop a nanomaterial suitable for long-term tracking of cancer cells in vivo and a method of producing the same. The nano material has excellent biocompatibility and has better optical stability than the conventional organic fluorescent agent, and is more suitable for application to the human body.

為達上述目的,本發明係提供一種奈米複合材料,其包含:一奈米金銀粒子;及一表面具硫醇基(thiol)之奈米鑽石,其係與該奈米金銀粒子連接。To achieve the above object, the present invention provides a nanocomposite comprising: one nano-gold silver particles; and a nano-diamond-containing nano-diamond bonded to the nano-gold silver particles.

較佳地,該表面具硫醇基之奈米鑽石係依序以聚乙二醇(PEG)及表面修飾劑修飾奈米鑽石而得。Preferably, the surface of the thiol-containing nano-diamond is obtained by sequentially modifying the nano-diamond with polyethylene glycol (PEG) and a surface modifier.

較佳地,該聚乙二醇之重量平均分子量為300~3000。Preferably, the polyethylene glycol has a weight average molecular weight of from 300 to 3,000.

較佳地,該表面修飾劑為亞胺環硫丁烷(iminothiolane)。Preferably, the surface modifying agent is iminothiolane.

本發明另提供一種細胞標定物,其包含:前述奈米複合材料;及一表面具硫醇基之標靶材料,其係與該奈米複合材料連接。The invention further provides a cell calibration comprising: the nano composite material; and a target material having a surface having a thiol group, which is linked to the nano composite material.

較佳地,該表面具硫醇基之標靶材料係以表面修飾劑修飾標靶材料而得。Preferably, the target material having a thiol group on the surface is obtained by modifying a target material with a surface modifier.

較佳地,該表面修飾劑為亞胺環硫丁烷。Preferably, the surface modifying agent is imine cyclothiobutane.

較佳地,該標靶材料為運鐵蛋白(transferrin)或含RGD序列之蛋白。Preferably, the target material is a transferrin or a protein comprising an RGD sequence.

較佳地,該細胞標定物之吸收範圍為200~1100 nm。Preferably, the cell calibration has an absorption range of 200 to 1100 nm.

本發明再提供一種細胞標定物之製造方法,其包含以下之步驟:提供表面具硫醇基之奈米鑽石之分散液;添加奈米金銀粒子之溶液至該分散液中,以得一混合液;及添加表面具硫醇基之標靶材料之水溶液至該混合液中,以得細胞標定物。The invention further provides a method for producing a cell calibration, comprising the steps of: providing a dispersion of a thiol-containing nano-diamond on a surface; adding a solution of nano-gold silver particles to the dispersion to obtain a mixed solution; And adding an aqueous solution of a target material having a surface having a thiol group to the mixed solution to obtain a cell calibrator.

較佳地,該分散液之製造方法包含以下之步驟:將經聚乙二醇修飾之奈米鑽石分散於水中;及添加表面修飾劑,使之與該聚乙二醇反應,以得該分散液。Preferably, the method for producing the dispersion comprises the steps of: dispersing a polyethylene glycol modified nano diamond in water; and adding a surface modifying agent to react with the polyethylene glycol to obtain the dispersion. liquid.

較佳地,該表面修飾劑為亞胺環硫丁烷。Preferably, the surface modifying agent is imine cyclothiobutane.

較佳地,該表面具硫醇基之標靶材料之水溶液的製造方法包含以下之步驟:將標靶材料添加至水中;及添加表面修飾劑,使之與該標靶材料反應,以得表面具硫醇基之標靶材料之水溶液。Preferably, the method for producing an aqueous solution of a target material having a thiol group on the surface comprises the steps of: adding a target material to water; and adding a surface modifier to react with the target material to obtain a surface. An aqueous solution of a target material having a thiol group.

較佳地,該標靶材料為運鐵蛋白或含RGD序列之蛋白。Preferably, the target material is transferrin or a protein containing an RGD sequence.

較佳地,該表面修飾劑為亞胺環硫丁烷。Preferably, the surface modifying agent is imine cyclothiobutane.

本發明所提供之奈米複合材料及細胞標定物可在短時間內製備而得,且具有優異之生物相容性,因此,適合於應用於生醫材料上。The nano composite material and the cell calibration material provided by the invention can be prepared in a short time and have excellent biocompatibility, and therefore are suitable for application to biomedical materials.

本發明係提供一種生物相容性優異之奈米複合材料及細胞標定物。具體而言,本發明之奈米複合材料係包含:一奈米金銀粒子;及一表面具硫醇基之奈米鑽石,其係與該奈米金銀粒子連接。而本發明所提供之細胞標定物係包含該奈米複合材料;及一表面具硫醇基之標靶材料,其係與該奈米複合材料連接。The present invention provides a nanocomposite and a cell calibrator excellent in biocompatibility. Specifically, the nanocomposite of the present invention comprises: one nano-gold silver particles; and a surface-containing thiol-containing nano-diamond connected to the nano-gold silver particles. The cell calibration provided by the present invention comprises the nano composite material; and a target material having a surface having a thiol group, which is linked to the nano composite material.

本發明所用之術語「奈米金銀粒子」係指中華民國第100111493號專利申請案所揭露者,該案以引用方式併入本文中。詳言之,該奈米金銀粒子係以下方式製備而得:(A)提供一混合液,其含有金離子及銀離子;(B)添加一還原劑至前述混合液中;及(C)添加一甲殼素,以得到一成長溶液,然後靜置前述成長溶液,並且,該奈米金銀粒子包含金成分;銀成分;及甲殼素,而其吸收範圍為600~1000 nm。於一較佳實施態樣中,該奈米金銀粒子為星狀奈米金銀粒子。The term "nano-gold-silver particles" as used in the present invention refers to the disclosure of the Patent Application No. 100111493, the disclosure of which is incorporated herein by reference. In detail, the nano gold and silver particles are prepared in the following manner: (A) providing a mixed liquid containing gold ions and silver ions; (B) adding a reducing agent to the foregoing mixture; and (C) adding a chitin to obtain a growth solution, and then to stand the growth solution, and the nano gold and silver particles contain a gold component; a silver component; and chitin, and the absorption range is 600 to 1000 nm. In a preferred embodiment, the nano-gold silver particles are star-shaped nano gold and silver particles.

本發明所用之表面具硫醇基之奈米鑽石係可以本領域周知之方法修飾奈米鑽石而得,較佳係依序以聚乙二醇及表面修飾劑修飾奈米鑽石而得。該表面修飾劑只要能與該PEG之末端官能基反應後能產生硫醇基即可,並無特別之限制。一般而言,該表面修飾劑為亞胺環硫丁烷,如2-亞胺環硫丁烷。在聚乙二醇方面,一般以未端修飾胺基之聚乙二醇為佳,因胺基有較佳之反應性,有助於與表面修飾劑反應之進行。該聚乙二醇之分子量亦無特別限制,一般來說,其重量平均分子量係在300~3000之範圍。The surface thiol-containing nano-diamonds used in the present invention can be obtained by modifying nano-diamonds by a method known in the art, preferably by sequentially modifying the nano-diamonds with polyethylene glycol and a surface modifying agent. The surface modifying agent is not particularly limited as long as it can react with the terminal functional group of the PEG to produce a thiol group. In general, the surface modifying agent is an imine cyclothiobutane such as 2-imine cyclothiobutane. In the case of polyethylene glycol, polyethylene glycol which is modified with an amine group is generally preferred, and the amine group has a preferred reactivity to facilitate the reaction with the surface modifier. The molecular weight of the polyethylene glycol is also not particularly limited, and generally, the weight average molecular weight thereof is in the range of 300 to 3,000.

於本發明中,該表面具硫醇基之標靶材料係可為本身表面即具有硫醇基之標靶材料,或係經表面修飾劑修飾後才於表面上具硫醇基之標靶材料。舉例而言,該表面具硫醇基之標靶材料係可藉由以亞胺環硫丁烷修飾運鐵蛋白或以亞胺環硫丁烷修飾含RGD序列之蛋白而得。特定而言,該含RGD序列之蛋白係具有癌細胞標靶性,其包含之胺基酸會對整合蛋白alphaIIbbeta3、alphaVbeta3、及alpha5betal產生特異性,但並不限於此。In the present invention, the surface material having a thiol group on the surface may be a target material having a thiol group on its surface, or a target material having a thiol group on the surface after being modified by a surface modifier. . For example, the target material having a thiol group on the surface can be obtained by modifying the transferrin with imine thiobutane or modifying the protein containing the RGD sequence with imine thiobutane. Specifically, the RGD-containing protein has a cancer cell target, and the amino acid contained therein is specific for the integrins alphaIIbbeta3, alphaVbeta3, and alpha5betal, but is not limited thereto.

由於硫醇基與金兩者間存在有絕佳之鍵結能力,因此,該表面具硫醇基之奈米鑽石較佳係透過該硫醇基以共價鍵與該奈米金銀粒子中之金連接。相同地,該表面具硫醇基之標靶材料較佳係透過該硫醇基以共價鍵與該奈米金銀粒子中之金連接。Since the thiol group and the gold have excellent bonding ability, the thiol group-containing nano-diamond is preferably covalently bonded to the nano-gold-silver particle through the thiol group. Gold connection. Similarly, the target material having a thiol group on the surface is preferably covalently bonded to the gold in the nano-gold silver particles through the thiol group.

本發明亦提供一種細胞標定物之製造方法,其包含以下之步驟:提供表面具硫醇基之奈米鑽石之分散液;添加奈米金銀粒子之溶液至該分散液中,以得一混合液;及添加表面具硫醇基之標靶材料之水溶液至該混合液中,以得細胞標定物。The invention also provides a method for producing a cell calibration, comprising the steps of: providing a dispersion of a surface thiol-containing nano-diamond; adding a solution of nano-gold silver particles to the dispersion to obtain a mixed solution; And adding an aqueous solution of a target material having a surface having a thiol group to the mixed solution to obtain a cell calibrator.

於本發明之實施態樣中,該分散液體之製造方法係可包含以下之步驟:首先,將經聚乙二醇修飾之奈米鑽石分散於水中,特定而言,將1 mg之經聚乙二醇修飾之奈米鑽石均勻分散於20 mL去離子水中。In the embodiment of the present invention, the method for producing the dispersion liquid may include the following steps: First, dispersing the polyethylene glycol modified nano diamond in water, specifically, 1 mg of polyethylene The diol-modified nano-diamond was uniformly dispersed in 20 mL of deionized water.

然後,添加表面修飾劑,使之與該聚乙二醇反應,以得該分散液。具體而言,添加亞胺環硫丁烷(如:2-亞胺環硫丁烷),並使所得之溶液靜置60分鐘,期間該亞胺環硫丁烷會與該聚乙二醇反應。Then, a surface modifying agent is added and reacted with the polyethylene glycol to obtain the dispersion. Specifically, an imine cyclothiobutane (eg, 2-imine cyclothiobutane) is added, and the resulting solution is allowed to stand for 60 minutes, during which the imine cyclothiobutane reacts with the polyethylene glycol. .

較佳地,該經聚乙二醇修飾之奈米鑽石分散於水中後之粒子尺寸為1~500 nm。Preferably, the polyethylene glycol modified nano diamond has a particle size of 1 to 500 nm after being dispersed in water.

於本發明之實施態樣中,該表面具硫醇基之標靶材料之水溶液的製造方法包含以下之步驟:將標靶材料添加至水中;及添加表面修飾劑,使之與該標靶材料反應,以得表面具硫醇基之標靶材料之水溶液。詳言之,將運鐵蛋白添加至水中後,添加2-亞胺環硫丁烷,並使所得之溶液靜置60分鐘,期間2-亞胺環硫丁烷會與標靶材料反應,進而獲得表面具硫醇基之運鐵蛋白之水溶液。In an embodiment of the present invention, the method for producing an aqueous solution of a target material having a thiol group on the surface comprises the steps of: adding a target material to water; and adding a surface modifier to the target material. The reaction is carried out to obtain an aqueous solution of a target material having a surface having a thiol group. In detail, after adding transferrin to water, 2-imine cyclothiobutane is added, and the resulting solution is allowed to stand for 60 minutes, during which 2-imine cyclic thiobutane reacts with the target material, and further An aqueous solution of transferrin having a thiol group on the surface is obtained.

值得注意的是,本發明中所有反應的溫度皆無須特別限制,不過,為便於操作,較佳係於室溫下進行反應。此外,若有必要,可再搭配一離心步驟,將製得之細胞標定物自前述混合液中分離出來。前述離心步驟的條件(包括轉速、時間和次數等)無須特別限制,只要可以達到分離前述之細胞標定物之目的即可。It is to be noted that the temperature of all the reactions in the present invention is not particularly limited, but, for ease of handling, it is preferred to carry out the reaction at room temperature. In addition, if necessary, the resulting cell calibrator can be separated from the mixture by a centrifugation step. The conditions of the aforementioned centrifugation step (including the number of rotations, time and number of times, etc.) are not particularly limited as long as the purpose of separating the aforementioned cell calibrator can be achieved.

由上可知,本發明之細胞標定物之製造方法極為簡單,因此,可於短時間內合成出。As apparent from the above, the method for producing the cell marker of the present invention is extremely simple, and therefore, it can be synthesized in a short time.

以下實施例係用於進一步了解本發明之優點,並非用於限制本發明之申請專利範圍。The following examples are intended to further understand the advantages of the present invention and are not intended to limit the scope of the invention.

實施例一:本發明奈米複合材料之製備Example 1: Preparation of Nano Composite Material of the Present Invention

於本發明實施例中所使用之聚乙二醇(PEG),係末端修飾胺基之聚乙二醇,其重量平均分子量為1500(PEG1500N )。該末端修飾胺基之聚乙二醇係由藥廠Sigma Aldrich所購得。The polyethylene glycol (PEG) used in the examples of the present invention is a terminally modified amine group polyethylene glycol having a weight average molecular weight of 1500 (PEG 1500 N ). The terminally modified amine based polyethylene glycol is commercially available from the pharmaceutical company Sigma Aldrich.

首先,將43.5毫克之PEG1500N 與625.4毫克之奈米鑽石於120℃下反應三天,即得經PEG1500N 修飾之奈米鑽石。First, 43.5 mg of PEG 1500N and 625.4 mg of nano diamond were reacted at 120 ° C for three days to obtain a PEG 1500 N modified nano diamond.

接著,將該經PEG1500N 修飾之奈米鑽石分散於水中,而得0.05 mg/mL經PEG1500N 修飾之奈米鑽石水溶液,之後,再加入10毫克的2-亞胺環硫丁烷添,並於室溫下均勻混合,使之反應60分鐘,而得表面具硫醇基之奈米鑽石之分散液。Next, the PEG 1500N modified nano diamond was dispersed in water to obtain 0.05 mg/mL PEG 1500N modified nano diamond aqueous solution, and then 10 mg of 2-imine cyclothiobutane was added, and The mixture was uniformly mixed at room temperature and allowed to react for 60 minutes to obtain a dispersion of a thiol-containing nano-diamond.

最後,於室溫下,將濃度20 ppm之奈米金銀粒子之溶液1毫升添加至該分散液中,並使之均勻混合。之後,將所得之混合液靜置60分鐘,即可獲得奈米複合材料之混合液,此混合液未經處理即可用於後續細胞標定物之製備。若將該混合液予以離心,即可分離出本實施例之奈米複合材料。此處所用之奈米金銀粒子溶液為中華民國第100111493號專利申請案之實施例一所用之含奈米金銀粒子之甲殼素溶液。奈米金銀粒子其製備方法包含以下步驟:(A)提供一混合液,其含有金離子及銀離子;(B)添加一還原劑至前述混合液中;及(C)添加一甲殼素,而得到一成長溶液,然後靜置前述成長溶液。。Finally, 1 ml of a solution of nano-gold silver particles having a concentration of 20 ppm was added to the dispersion at room temperature, and uniformly mixed. Thereafter, the resulting mixture was allowed to stand for 60 minutes to obtain a mixture of nanocomposites, which was used without any treatment for the preparation of subsequent cell standards. When the mixture is centrifuged, the nanocomposite of the present embodiment can be separated. The nano-gold-silver particle solution used herein is a chitin solution containing nano-gold silver particles used in Example 1 of the Patent Application No. 100111493 of the Republic of China. The preparation method of the nano gold silver particles comprises the steps of: (A) providing a mixed liquid containing gold ions and silver ions; (B) adding a reducing agent to the mixture; and (C) adding a chitin. A growth solution was obtained, and then the growth solution was allowed to stand. .

實施例二:本發明細胞標定物之製備(標靶材料為運鐵蛋白 ) Example 2: Preparation of cell calibrator of the invention (target material is transferrin )

將1毫克之運鐵蛋白添加至1mL水中,接著,於室溫下加入10毫克的2-亞胺環硫丁烷,使之與該運鐵蛋白反應,將所得之溶液靜置60分鐘。1 mg of transferrin was added to 1 mL of water, and then 10 mg of 2-imine cyclothiobutane was added thereto at room temperature to react with the transferrin, and the resulting solution was allowed to stand for 60 minutes.

接著,將該靜置後之溶液加至實施例一中所述之奈米複合材料之混合液中,接著靜置所得之溶液60分鐘,即可獲得具有標靶性質之細胞標定物混合液。將該混合溶液於10,000rpm離心三次,以分離出其中之結晶固體,即可獲得本實施例之具有標靶性質之細胞標定物。Next, the solution after standing was added to the mixture of the nanocomposites described in Example 1, and then the resulting solution was allowed to stand for 60 minutes to obtain a mixture of cell standards having the target properties. The mixed solution was centrifuged three times at 10,000 rpm to separate the crystalline solid therein, thereby obtaining a cell calibrator having the target properties of the present example.

實施例三:本發明細胞標定物之製備(標靶材料為含RGD序列之蛋白)Example 3: Preparation of cell calibration of the present invention (target material is a protein containing an RGD sequence)

除了將實施例二之運鐵蛋白改成含RGD序列之蛋白外,其餘與實施例二之方法相同,以製得實施例三之細胞標定物。RGD序列之蛋白包含下數三種不同之胺基酸,其分別為天冬胺酸、甘胺酸與精胺酸。The cell calibration of Example 3 was prepared in the same manner as in Example 2 except that the transferrin of Example 2 was changed to the protein containing the RGD sequence. The protein of the RGD sequence comprises the following three different amino acids, which are aspartic acid, glycine and arginine, respectively.

實施例四:細胞標定物之特性分析Example 4: Characterization of cell calibrators

[外觀][Exterior]

請參第一A圖及第一B圖,其係分別顯示經末端修飾胺基之PEG修飾之奈米鑽石(即經PEG1500N 修飾之奈米鑽石)及實施例二之細胞標定物之穿隧式電子顯微鏡照片。奈米鑽石表面之官能基經PEG1500N 修飾後,會擁有眾多之一級胺基分佈於其表面,本發明即係利用該胺基與表面修飾劑(2-亞胺環硫丁烷)反應,使經PEG1500N 修飾之奈米鑽石之表面官能基從胺基轉變成硫醇基。而硫醇基與金兩者間具有絕佳之鍵結能力,利用此特性,將表面具硫醇基之奈米鑽石與奈米金銀粒子進行反應。同時,利用標靶材料亦具有眾多之一級胺基之特性,以前述相同之方法,將標靶材料(運鐵蛋白)修飾成表面係具硫醇基,再與反應後之奈米金銀粒子鍵結,即可得具有標靶性質之細胞標定物。第一A圖及第一圖B顯示,該經PEG1500N 修飾之奈米鑽石及實施例二之細胞標定物之粒徑確屬奈米等級。Please refer to the first A and the first B, which respectively show the PEG-modified nano-diamond modified with amino acid (ie, PEG 1500N- modified nano-diamond) and the cell calibration of the cell calibrator of Example 2. Electron micrograph. The functional group on the surface of the nanodiamond is modified by PEG 1500N to have a plurality of primary amine groups distributed on the surface thereof, and the present invention utilizes the amine group to react with a surface modifier (2-imine cyclothiobutane) to make The surface functional groups of the PEG 1500N modified nanodiamonds are converted from amine groups to thiol groups. The thiol group and the gold have excellent bonding ability, and the thiol-containing nano-diamonds on the surface are reacted with the nano-gold silver particles by using this property. At the same time, the target material also has a plurality of characteristics of a single amine group, and the target material (transferrin) is modified into a surface system having a thiol group by the same method as described above, and then reacted with the nano silver gold particle bond after the reaction. To obtain a cell calibrator with targeted properties. The first A and the first panel B show that the particle size of the PEG 1500N modified nanodiamond and the cell calibrator of Example 2 is indeed a nanometer grade.

[吸收光譜][Absorption spectrum]

第二圖為經PEG1500N 修飾之奈米鑽石、奈米金銀粒子、實施例一之奈米複合材料及實施例二之細胞標定物之吸收光譜圖。該圖顯示,奈米鑽石表面之官能基經PEG1500N 修飾後,會具有螢光性質,且經PEG1500N 修飾之奈米鑽石之吸收峰值隨著波長變短而增加。奈米金銀粒子則在700 nm和1000 nm皆有吸收波峰,而該奈米金銀粒子中之甲殼素之吸收則位於紫外光區。實施例一之奈米複合材料及實施例二之細胞標定物之吸收則綜合上述經PEG1500N 修飾之奈米鑽石及奈米金銀粒子之特性,於700 nm和1000 nm皆有些微之吸收波峰,且吸收峰值隨著波長變短而增加。The second figure is an absorption spectrum of the nano-diamond modified with PEG 1500N , nano-gold silver particles, the nano composite of Example 1, and the cell calibrator of Example 2. The figure shows that the functional groups on the surface of the nanodiamond are modified by PEG 1500N to have a fluorescent property, and the absorption peak of the nano-diamond modified with PEG 1500N increases as the wavelength becomes shorter. The nano gold and silver particles have absorption peaks at 700 nm and 1000 nm, and the absorption of chitin in the nano gold and silver particles is in the ultraviolet region. The absorption of the nanocomposite of Example 1 and the cell calibrator of Example 2 combines the characteristics of the above-mentioned PEG 1500N- modified nano-diamond and nano-gold-silver particles, and some absorption peaks are slightly observed at 700 nm and 1000 nm. And the absorption peak increases as the wavelength becomes shorter.

[傅立葉紅外光光譜][Fourier infrared spectroscopy]

第三圖為經PEG1500N 修飾之奈米鑽石、表面具硫醇基之奈米鑽石、及實施例一之奈米複合材料之傅立葉紅外光光譜。藉由該光譜儀可鑑定奈米粒子表面修飾之官能基。由第三A圖顯示,3425 cm-1 、1630 cm-1 、2920 cm-1 、1098 cm-1 是有吸收峰存在,其表示經PEG1500N 修飾之奈米鑽石表面具N-H(3425 cm-1 )、(N)C=O(1630 cm-1 )、C-H(2920 cm-1 )、C-O(1098 cm-1 )之官能基,此即表示該奈米鑽石經修飾後,其表面帶有PEG主結構之官能基。The third panel shows the Fourier transform infrared spectrum of the PEG 1500N modified nano-diamond, the surface thiol-containing nano-diamond, and the nano-composite of the first embodiment. The functional group of the surface modification of the nanoparticle can be identified by the spectrometer. As shown in the third A diagram, 3425 cm -1 , 1630 cm -1 , 2920 cm -1 , and 1098 cm -1 have absorption peaks, which indicate that the surface of the nano-diamond modified with PEG 1500N has NH (3425 cm -1 ). ), (N) C=O (1630 cm -1 ), CH (2920 cm -1 ), CO (1098 cm -1 ), which means that the nano-diamond has a modified surface with PEG The functional group of the main structure.

而該PEG1500N 之末端為N-H官能基,其會與2-亞胺環硫丁烷反應,進行開環反應,其末端之官能基會轉變成硫醇(S-H)官能基。雖然S-H之官能基之吸收峰於傅立葉紅外光光譜上並不明顯,但可藉由開環反應後之N-H官能基之吸收峰來證實表面具硫醇基之奈米鑽石之生成。具體而言,開環反應後,會形成C=N之官能基,其會導致原本N-H之官能基之吸收峰位移,會位移至3137 cm-1 ,此可間接證明PEG1500N 末端之N-H已與2-亞胺環硫丁烷反應,進而證實S-H官能基之生成。由第三B圖之結果顯示,在3137 cm-1 確實有吸收峰產生,因此,證實表面具硫醇基之奈米鑽石成功被合成出。The end of the PEG 1500N is an NH functional group which reacts with 2-imine cyclic thiobutane to carry out a ring opening reaction, and the functional group at the end thereof is converted into a thiol (SH) functional group. Although the absorption peak of the functional group of SH is not apparent on the Fourier infrared spectrum, the formation of a thiol-containing nano-diamond on the surface can be confirmed by the absorption peak of the NH functional group after the ring-opening reaction. Specifically, after the ring-opening reaction, a functional group of C=N is formed, which causes the absorption peak displacement of the original NH functional group to shift to 3137 cm -1 , which indirectly proves that the NH of the PEG 1500 N end has The 2-imine cyclothiobutane reaction further confirmed the formation of the SH functional group. From the results of the third B chart, it was found that an absorption peak was actually produced at 3137 cm -1 , and therefore, it was confirmed that the surface thiol-containing nano-diamond was successfully synthesized.

表面具S-H基團之奈米鑽石可藉由該S-H官能基與奈米金銀粒子反應,來形成本發明之奈米複合材料。利用傅立葉紅外光譜儀可發現該奈米複合材料除上述之官能基外,亦有甲殼素之官能基訊號,此因實施例所用之奈米金銀粒子為中華民國第100111493號所述者,而該奈米金銀粒子係含當作表面修飾劑且同時兼具穩定結構之功能的甲殼素成分。A nano-diamond having an S-H group on the surface can be reacted with nano-gold silver particles by the S-H functional group to form the nanocomposite of the present invention. Using a Fourier transform infrared spectroscopy, it can be found that the nano composite material has a functional signal of chitin in addition to the above functional groups, and the nano gold and silver particles used in the examples are those described in the Republic of China No. 100111493, and the nai The rice gold silver particles contain a chitin component which functions as a surface modifier and at the same time has a stable structure.

[螢光特性][fluorescent characteristics]

第四圖中之A至D列係分別顯示肝癌細胞(作為對照組)、食入經PEG1500N 修飾之奈米鑽石之肝癌細胞、食入實施例一奈米複合材料之肝癌細胞、食入實施例二細胞標定物之肝癌細胞的共軛焦螢光圖,其中(a)欄係明視野(bright field)之影像;(b)欄係細胞轉染後之影像;(c)欄係來自經PEG1500N 修飾之奈米鑽石之螢光訊號;及(d)欄係合併(merged)後之影像。透過該些螢光圖來檢視實施例一之奈米複合材料及實施例二之細胞標定物之螢光特性。第四圖中之A列係作為對照組,由第四圖中A列(a)欄之結果可明顯發現,該肝癌細胞(J5)並無自體螢光,但經過螢光染劑(諸如hochest 33342)有機螢光轉染後,可標定藍色之細胞核於細胞內之位置,如第四圖中A列(b)欄所示。利用共軛焦顯微鏡量測細胞穿透光譜與細胞核位置可確定細胞內部並無紅色之自體螢光。第四圖中B列為細胞食入經PEG1500N 修飾之奈米鑽石後之共軛焦螢光圖,其可確定經PEG1500N 修飾之奈米鑽石確實具有紅色螢光,且會經由細胞胞吞現象,將經PEG1500N 修飾之奈米鑽石吞入細胞內部。將實施例一之奈米複合材料或實施例二之細胞標定物與細胞培養後,同樣會有細胞胞吞現象且同時可觀測該化合物之螢光現象,如第四圖中C及D列。In the fourth figure, columns A to D show liver cancer cells (as a control group), liver cancer cells ingested with PEG 1500N- modified nano-diamonds, liver cancer cells ingested in the first embodiment of the nano-composite, and ingestion Example 2: Conjugate pyrogram of liver cancer cells of a cell calibration, wherein (a) is an image of a bright field; (b) an image of a cell after transfection; (c) a column derived from PEG 1500N The fluorescent signal of the modified nano diamond; and (d) the image after the merged. The fluorescence characteristics of the nanocomposite of Example 1 and the cell calibrator of Example 2 were examined by the fluorescence maps. The A column in the fourth figure is used as a control group. It can be clearly seen from the results in column A (a) of the fourth figure that the liver cancer cells (J5) have no autofluorescence but pass the fluorescent dye (such as Hochest 33342) After organic fluorescent transfection, the position of the blue nuclei in the cells can be calibrated, as shown in column A (b) of the fourth figure. Using a conjugated focal microscope to measure cell penetration spectra and nuclear location, it was determined that there was no red autofluorescence inside the cells. In the fourth figure, column B is the conjugated fluorescein image of the cells after ingestion of PEG 1500N- modified nano-diamonds. It can be confirmed that the PEG 1500N- modified nano-diamond does have red fluorescence and undergoes cell endocytosis. The PEG 1500N modified nano diamond was swallowed inside the cell. After the nanocomposite of Example 1 or the cell calibrator of Example 2 is cultured with the cells, there is also a cell endocytosis phenomenon and the fluorescence phenomenon of the compound can be observed at the same time, as in the fourth and fourth columns.

相較於常用之有機螢光染劑而言,經末端修飾胺基之PEG1500N 修飾之奈米鑽石具有較佳之光學穩定性。如文獻Anal. Chem .,2009,81,8687-8694所揭示之有機螢光染料經過共軛焦顯微鏡照射400秒後,該有機螢光會由於化合物之結構改變而淬滅。由於有機螢光受限於光熱不穩定之特性,無法用於長期之細胞內部追蹤,而於生物實驗上受到限制。然,本發明之奈米複合材料並不會受到光能照射而導致其結構之改變,進而影響其螢光之強度。請參閱第五圖,第五A圖係本發明之奈米複合材料與有機螢光(calcein)於共軛焦顯微鏡下照射35秒前(左三圖)與後(右三圖)之影像。該六張圖之上兩張圖代表細胞經有機螢光染色後之綠色螢光;中間兩張之圖為奈米複合材料之螢光;下兩張為將上述之兩種螢光訊號與細胞穿透圖譜合併後之圖譜。由左面之圖與右面之圖對照後可發現,經過共軛焦顯微鏡之光源照射後,該綠色螢光受到光照而光解,反之,奈米複合材料之螢光並未有任何明顯之光解現象;同時,利用第五B圖為可觀察到,其兩種螢光於不同光照時間下,其螢光強度改變之對比;第五C圖係本發明之奈米複合材料與有機螢光之螢光訊號於照射前後之比值與時間作圖,即可發現,有機螢光訊號於短時間照射後,會有光解之現象,導致螢光訊號之淬滅,反之,本發明之奈米複合材料之螢光並未有任何之改變。結果顯示,本發明之奈米複合材料並不會受到光能照射而導致其結構之改變而影響螢光之強度;相對地,有機螢光經過照射,會導致該螢光之淬滅。The end-modified amine-based PEG 1500N modified nano-diamond has better optical stability than the conventional organic fluorescent dye. After the organic fluorescent dye disclosed in the literature Anal. Chem ., 2009, 81, 8687-8694 is irradiated by a conjugated focus microscope for 400 seconds, the organic fluorescent light is quenched due to structural changes of the compound. Since organic fluorescence is limited by the characteristics of photothermal instability, it cannot be used for long-term intracellular tracking, but is limited in biological experiments. However, the nanocomposite of the present invention is not exposed to light energy to cause a change in its structure, thereby affecting the intensity of its fluorescence. Please refer to the fifth figure. The fifth A is an image of the nano composite material of the present invention and organic fluorescence (calcein) irradiated 35 seconds before (left 3rd) and rear (3rd right) under a conjugated focus microscope. The two images above the six images represent the green fluorescence of the cells after organic fluorescence staining; the middle two images are the fluorescence of the nanocomposite; the next two are the two kinds of fluorescent signals and cells Pass through the map of the merged map. By comparing the image on the left with the image on the right, it can be found that after the illumination of the light source of the conjugated focal microscope, the green fluorescent light is photolyzed by illumination, whereas the fluorescence of the nano composite material does not have any obvious photolysis. At the same time, using the fifth B picture, it can be observed that the fluorescence of the two kinds of fluorescence is changed under different illumination time; the fifth C picture is the nano composite material of the invention and the organic fluorescent light By plotting the ratio of the fluorescence signal before and after the irradiation and the time, it can be found that after the organic fluorescent signal is irradiated for a short time, there is a phenomenon of photolysis, which leads to quenching of the fluorescent signal, and conversely, the nano composite of the present invention. The fluorescence of the material has not changed. The results show that the nanocomposite of the present invention is not exposed to light energy and causes a change in its structure to affect the intensity of the fluorescent light; relatively, the organic fluorescent light is irradiated, which causes quenching of the fluorescent light.

[生物相容性][Biocompatibility]

由於本發明所使用之材料皆具有優異之生物相容性,因此,除了提供本發明之奈米複合材料及細胞標定物良好的光穩定性之外,亦提供優異的生物相容性。於此檢驗中,將經PEG1500N 修飾之奈米鑽石(ND)、本發明之奈米複合材料(ND-Au Star)、實施例二之細胞標定物(ND-Au Star-Tf)或實施例三之細胞標定物(ND-Au Star-RGD),與肝癌細胞(J-5)或肺癌細胞(A549)共同培養,然後觀察細胞存活率,以評估生物相容性。Since the materials used in the present invention have excellent biocompatibility, in addition to providing good light stability of the nanocomposite and cell calibrator of the present invention, excellent biocompatibility is also provided. In this test, a nano diamond (ND) modified with PEG 1500N , a nano composite material of the present invention (ND-Au Star), a cell standard of the second embodiment (ND-Au Star-Tf) or an example The cell standard (ND-Au Star-RGD) was co-cultured with liver cancer cells (J-5) or lung cancer cells (A549), and cell viability was observed to evaluate biocompatibility.

檢驗結果如第六A圖及第六B圖所示,隨著濃度提升,所有材料共同培養之細胞存活率皆與對照組相差無幾。此實驗結果顯示本發明之奈米複合材料及細胞標定物具優異的生物相容性。The test results are shown in Fig. 6A and Fig. BB. As the concentration increases, the cell viability of all materials co-cultured is comparable to that of the control group. The results of this experiment show that the nanocomposite and cell calibrator of the present invention have excellent biocompatibility.

[細胞胞吞量之量測][Measurement of cell endocytosis]

第七A圖為本發明之奈米複合材料及實施例二之細胞標定物之流式細胞儀的細胞螢光數量圖。本發明之奈米複合材料可藉由流式細胞儀進行奈米鑽石之螢光量測,細胞藉由胞吞現象將該奈米複合材料吞入體內後,該細胞即具螢光之訊號,於此可藉由流式細胞儀量測具螢光訊號的細胞數量,可證明奈米鑽石於細胞內部之濃度,量測結果顯示於第七A圖。第七A圖顯示,本發明之奈米複合材料與經修飾之標靶材料(運鐵蛋白)連接後,具螢光之細胞數量上升,表示標靶材料可增加細胞胞吞之效果。第七B圖為利用感應耦合電漿質譜儀量測奈米複合材料及實施例二之細胞標定物之金濃度所得之結果。該金濃度測得之結果與第七A圖所示之結果近似,此可證明該本發明之細胞標定物同時具備有標靶與顯影之功用。Figure 7A is a graph showing the amount of cell fluorescence of the flow cytometer of the nanocomposite of the present invention and the cell calibrator of Example 2. The nano composite material of the invention can be used for fluorescence measurement of nano diamond by flow cytometry, and the cell has a fluorescent signal after the cell is swallowed by the endocytosis phenomenon. Here, the number of cells with fluorescent signals can be measured by flow cytometry, and the concentration of the nano-diamond inside the cells can be confirmed. The measurement results are shown in Figure 7A. Figure 7A shows that after the nanocomposite of the present invention is linked to the modified target material (transferrin), the number of cells with fluorescence increases, indicating that the target material can increase the effect of cell endocytosis. Figure 7B is a graph showing the results of measuring the gold concentration of the nanocomposite and the cell calibrator of Example 2 by inductively coupled plasma mass spectrometry. The result of the gold concentration measurement is similar to the result shown in Fig. A, which proves that the cell calibration of the present invention has both the function of target and development.

[溫熱治療][warm treatment]

利用經PEG1500N 修飾之奈米鑽石、本發明之複合材料或實施例二之細胞標定物與癌細胞培養12小時後,藉由照射800 nm紅外光進行溫熱治療之研究,結果顯示於第八圖中。第八圖經PEG1500N 修飾之奈米鑽石、本發明之複合材料或實施例二之細胞標定物與癌細胞培養,接著進行溫熱治療後之所得之觀察結果,其中A列為對照組,其為經PEG1500N 修飾之奈米鑽石之觀察結果;B列為本發明之複合材料之觀察結果;C列為實施例二之細胞標定物之觀察結果;(a)欄為1.2W之觀察結果;(b)欄為1.4W之觀察結果;(c)欄為2.3W之觀察結果。另外,第八圖中各圖中左下角之影像為方形區塊之細胞經過照射後之螢光圖譜。如第八圖所示,利用純癌細胞與細胞內部僅有經PEG1500N 修飾之奈米鑽石之細胞進行低能量(1.2與1.4 W)或高能量(2.3 W)之照射後,該癌細胞未有任何之改變。然,加入有複合材料與細胞標定物之癌細胞進行照射後,藉由台酚藍(trypan blue)進行死亡細胞之染色,發現該癌細胞會有凋零或死亡之現象,其中細胞標定物即使於低能量1.2 W下之照射亦有良好之溫熱治療效果。After incubation with cancer cells modified with PEG 1500N , the composite of the present invention or the cell calibrator of Example 2, and the cancer cells for 12 hours, the results of the thermotherapy treatment by irradiation with 800 nm infrared light were shown in the eighth In the picture. Figure 8 shows the results obtained by PEG 1500N modified nano diamond, the composite material of the present invention or the cell calibrator of Example 2 and cancer cells, followed by warming treatment, wherein A is a control group, The observation results of the nano diamond modified by PEG 1500N ; B is the observation result of the composite material of the present invention; C is the observation result of the cell calibration object of the second embodiment; and the column (a) is the observation result of 1.2W; Column (b) is the observation of 1.4W; column (c) is the observation of 2.3W. In addition, the image in the lower left corner of each figure in the eighth figure is a fluorescence spectrum of the cells after the square block is irradiated. As shown in Figure 8, after using pure cancer cells and cells with only PEG 1500N- modified nano-diamonds inside the cells for low-energy (1.2 and 1.4 W) or high-energy (2.3 W), the cancer cells are not There are any changes. However, after the cancer cells with the composite material and the cell calibrator were irradiated, the dead cells were stained with trypan blue, and the cancer cells were found to have fading or death, and the cell calibrator was even Low-energy 1.2 W exposure also has a good warming effect.

此外,請參看第八圖中各圖左下角之螢光圖譜。由於所使用之有機螢光為一熱敏感之螢光,其受到溫度之改變後,其螢光會有淬滅之現象(如圖中較黑之方形區塊),此現象可同時比對細胞死亡之現象。如此,即可證明本發明之細胞標定物係具標靶、照影與溫熱治療特性之多功能性材料。In addition, please refer to the fluorescence map in the lower left corner of each figure in the eighth figure. Since the organic fluorescent light used is a heat-sensitive fluorescent light, after the temperature is changed, the fluorescent light is quenched (the black square block in the figure), which can simultaneously align the cells. The phenomenon of death. Thus, it can be demonstrated that the cell marker of the present invention is a multifunctional material having a target, a phototherapy and a thermotherapy property.

綜上所述,本發明之奈米複合材料及細胞標定物均具優異的生物相容性,且具有較傳統之有機螢光劑更佳之光學穩定性,因此,更適合應用於人體上。並且,本發明之細胞標定物係具標靶、照影與溫熱治療特性,實有助於癌症治療方面之研究。In summary, the nano composite material and the cell standard of the present invention have excellent biocompatibility and have better optical stability than the conventional organic fluorescent agent, and therefore are more suitable for application to the human body. Moreover, the cell calibration system of the present invention has the characteristics of target, phototherapy and thermotherapy, and is beneficial to the research of cancer treatment.

其它實施態樣Other implementations

所有揭露於本發明書之特徵係可使用任何方式結合。本說明書所揭露之特徵可使用相同、相等或相似目的的特徵取代。因此,除了特別陳述強調處之外,本說明書所揭露之特徵係為一系列相等或相似特徵中的一個實施例。All features disclosed in this disclosure can be combined in any manner. Features disclosed in this specification can be replaced with features of the same, equivalent or similar purpose. Therefore, the features disclosed in this specification are one of a series of equivalent or similar features.

此外,依據本說明書揭露之內容,熟悉本技術領域者係可輕易依據本發明之基本特徵,在不脫離本發明之精神與範圍內,針對不同使用方法與情況作適當改變與修飾,因此,其它實施態樣亦包含於申請專利範圍中。In addition, according to the disclosure of the present specification, those skilled in the art can easily make appropriate changes and modifications to different methods and situations without departing from the spirit and scope of the present invention. The implementation aspect is also included in the scope of the patent application.

第一A圖係顯示經PEG1500N 修飾之奈米鑽石之穿隧式電子顯微鏡照片。The first A graph shows a tunneling electron micrograph of a nano diamond modified with PEG 1500N .

第一B圖係顯示實施例二之細胞標定物之穿隧式電子顯微鏡照片。The first B panel shows a tunneling electron micrograph of the cell calibrator of Example 2.

第二圖為經PEG1500N 修飾之奈米鑽石、奈米金銀粒子、實施例一之奈米複合材料及實施例二之細胞標定物之吸收光譜圖。The second figure is an absorption spectrum of the nano-diamond modified with PEG 1500N , nano-gold silver particles, the nano composite of Example 1, and the cell calibrator of Example 2.

第三A圖為經PEG1500N 修飾之奈米鑽石之傅立葉紅外光光譜。Figure A is a Fourier infrared spectrum of nano-diamonds modified with PEG 1500N .

第三B圖為表面具硫醇基之奈米鑽石之傅立葉紅外光光譜。The third B is a Fourier infrared spectrum of a nano-diamond with a thiol group.

第三C圖為實施例一之奈米複合材料之傅立葉紅外光光譜。The third C is a Fourier infrared spectrum of the nano composite of Example 1.

第四圖為肝癌細胞(作為對照組)、食入經PEG1500N 修飾之奈米鑽石之肝癌細胞、食入實施例一奈米複合材料之肝癌細胞、食入實施例二細胞標定物之肝癌細胞的共軛焦螢光圖。The fourth picture shows liver cancer cells (as a control group), liver cancer cells ingested with PEG 1500N modified nano diamond, liver cancer cells ingested in the first embodiment of the nanocomposite, and liver cancer cells ingested in the second cell calibration sample. Conjugate focal fluorescent light.

第五A圖係本發明之奈米複合材料與有機螢光於共軛焦顯微鏡下照射35秒前與照射35秒後之影像。Fig. 5A is an image of the nanocomposite of the present invention and organic fluorescent light irradiated 35 seconds before and 35 seconds after irradiation under a conjugated focus microscope.

第五B圖係本發明之奈米複合材料與有機螢光於共軛焦顯微鏡下照射前與照射後之放大之影像。Figure 5B is an enlarged image of the nanocomposite of the present invention and the organic fluorescence before and after irradiation under a conjugated focus microscope.

第五C圖係本發明之奈米複合材料與有機螢光於共軛焦顯微鏡下照射35秒後之淬滅趨勢圖。The fifth C is a quenching trend diagram of the nanocomposite of the present invention and organic fluorescence after 35 seconds of irradiation under a conjugated focus microscope.

第六A圖係經PEG1500N 修飾之奈米鑽石、本發明之奈米複合材料、實施例二之細胞標定物或實施例三之細胞標定物,與肝癌細胞(J-5)共同培養後,細胞存活率之觀察結果。6A is a PEG 1500N modified nano diamond, a nanocomposite of the present invention, a cell calibrator of Example 2 or a cell calibrator of Example 3, and co-cultured with liver cancer cells (J-5). Observation of cell viability.

第六B圖係經PEG1500N 修飾之奈米鑽石、本發明之奈米複合材料、實施例二之細胞標定物或實施例三之細胞標定物,與肺癌細胞(A549)共同培養後,細胞存活率之觀察結果。Figure 6B is a nano-diamond modified with PEG 1500N , a nanocomposite of the present invention, a cell calibrator of Example 2 or a cell calibrator of Example 3, and co-cultured with lung cancer cells (A549), the cells survive The observation of the rate.

第七A圖為本發明之奈米複合材料及實施例二之細胞標定物之流式細胞儀的細胞螢光數量圖,其中ND-Au表示本發明之奈米複合材料,ND-Au-Tf代表實施例二之細胞標定物。Figure 7A is a graph showing the amount of cell fluorescence of the flow cytometer of the nanocomposite of the present invention and the cell calibrator of Example 2, wherein ND-Au represents the nanocomposite of the present invention, ND-Au-Tf Representative of the cell calibrator of Example 2.

第七B圖為以感應耦合電漿質譜儀量測本發明之奈米複合材料及實施例二之細胞標定物所得到之金濃度圖,其中ND-Au表示本發明之奈米複合材料,ND-Au-Tf代表實施例二之細胞標定物。Figure 7B is a graph showing the gold concentration obtained by measuring the nanocomposite of the present invention and the cell calibrator of the second embodiment by an inductively coupled plasma mass spectrometer, wherein ND-Au represents the nanocomposite of the present invention, ND -Au-Tf represents the cell calibrator of Example 2.

第八圖係經PEG1500N 修飾之奈米鑽石、本發明之複合材料或實施例二之細胞標定物與癌細胞培養,接著進行溫熱治療後之所得之觀察結果。The eighth figure is the observation obtained by PEG 1500N- modified nanodiamond, the composite material of the present invention or the cell calibrator of Example 2 and cancer cells, followed by warming treatment.

Claims (15)

一種奈米複合材料,其包含:一星狀奈米金銀粒子;及一表面具硫醇基之奈米鑽石,其係與該奈米金銀粒子連接。 A nanocomposite comprising: a star-shaped nano-gold silver particle; and a surface thiol-containing nano-diamond connected to the nano-gold silver particle. 如申請專利範圍第1項所述之奈米複合材料,其中該表面具硫醇基之奈米鑽石係依序以聚乙二醇及表面修飾劑修飾奈米鑽石而得。 The nanocomposite according to claim 1, wherein the thiol-containing nano-diamond is obtained by sequentially modifying a nano-diamond with polyethylene glycol and a surface modifier. 如申請專利範圍第2項所述之奈米複合材料,其中該聚乙二醇之重量平均分子量為300~3000。 The nano composite material according to claim 2, wherein the polyethylene glycol has a weight average molecular weight of 300 to 3,000. 如申請專利範圍第2項所述之奈米複合材料,其中該表面修飾劑為亞胺環硫丁烷(iminothiolane)。 The nanocomposite of claim 2, wherein the surface modifier is iminothiolane. 一種細胞標定物,其包含:申請專利範圍第1項之奈米複合材料;及一表面具硫醇基之標靶材料,其係與該奈米複合材料連接。 A cell calibration comprising: a nanocomposite of claim 1; and a target material having a surface having a thiol group attached to the nanocomposite. 如申請專利範圍第5項所述之細胞標定物,其中該表面具硫醇基之標靶材料係以表面修飾劑修飾標靶材料而得。 The cell calibrator according to claim 5, wherein the target material having a thiol group on the surface is obtained by modifying a target material with a surface modifier. 如申請專利範圍第6項所述之細胞標定物,其中該表面修飾劑為亞胺環硫丁烷。 The cell calibrator of claim 6, wherein the surface modifying agent is imine thiobutane. 如申請專利範圍第6項所述之細胞標定物,其中該標靶材料為運鐵蛋白或含RGD序列之蛋白。 The cell calibrator of claim 6, wherein the target material is transferrin or a protein comprising an RGD sequence. 如申請專利範圍第5項所述之細胞標定物,其中該標定物之吸收範圍為200~1100nm。 The cell calibrator according to claim 5, wherein the calibration range of the calibration is 200 to 1100 nm. 一種細胞標定物之製造方法,其包含以下之步驟:提供表面具硫醇基之奈米鑽石之分散液;添加星狀奈米金銀粒子之溶液至該分散液中,以得 一混合液;及添加表面具硫醇基之標靶材料之水溶液至該混合液中,以得細胞標定物。 A method for producing a cell calibrator, comprising the steps of: providing a dispersion of a thiol-containing nano-diamond on a surface; adding a solution of star-shaped nano-gold silver particles to the dispersion to obtain a mixed solution; and an aqueous solution of a target material having a surface having a thiol group added thereto to obtain a cell calibrator. 如申請專利範圍第10項所述之製造方法,其中該分散液之製造方法包含以下之步驟:將經聚乙二醇修飾之奈米鑽石分散於水中;及添加表面修飾劑,使之與該聚乙二醇反應,以得該分散液。 The manufacturing method of claim 10, wherein the method for producing the dispersion comprises the steps of: dispersing a polyethylene glycol modified nano diamond in water; and adding a surface modifying agent to the same The polyethylene glycol was reacted to obtain the dispersion. 如申請專利範圍第11項所述之製造方法,其中該表面修飾劑為亞胺環硫丁烷。 The manufacturing method according to claim 11, wherein the surface modifying agent is imine cyclothiobutane. 如申請專利範圍第10項所述之製造方法,其中該表面具硫醇基之標靶材料之水溶液的製造方法包含以下之步驟:將標靶材料添加至水中;及添加表面修飾劑,使之與該標靶材料反應,以得表面具硫醇基之標靶材料之水溶液。 The manufacturing method according to claim 10, wherein the method for producing an aqueous solution having a target material having a surface of a thiol group comprises the steps of: adding a target material to water; and adding a surface modifying agent to make Reacting with the target material to obtain an aqueous solution of a target material having a surface of a thiol group. 如申請專利範圍第13項所述之製造方法,其中該標靶材料為運鐵蛋白或含RGD序列之蛋白。 The method of manufacture of claim 13, wherein the target material is transferrin or a protein comprising an RGD sequence. 如申請專利範圍第13項所述之製造方法,其中該表面修飾劑為亞胺環硫丁烷。 The manufacturing method according to claim 13, wherein the surface modifying agent is imine cyclothiobutane.
TW101106151A 2012-02-24 2012-02-24 Cell marker and method for making the same TWI464267B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW101106151A TWI464267B (en) 2012-02-24 2012-02-24 Cell marker and method for making the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW101106151A TWI464267B (en) 2012-02-24 2012-02-24 Cell marker and method for making the same

Publications (2)

Publication Number Publication Date
TW201335374A TW201335374A (en) 2013-09-01
TWI464267B true TWI464267B (en) 2014-12-11

Family

ID=49627319

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101106151A TWI464267B (en) 2012-02-24 2012-02-24 Cell marker and method for making the same

Country Status (1)

Country Link
TW (1) TWI464267B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007122259A1 (en) * 2006-04-25 2007-11-01 Centre National De La Recherche Scientifique (Cnrs) Functionalization of gold nanoparticles with oriented proteins. application to the high-density labelling of cell membranes
WO2009136741A1 (en) * 2008-05-07 2009-11-12 Seoul National University Industry Foundation Novel au / ag core-shell composite useful for biosensor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007122259A1 (en) * 2006-04-25 2007-11-01 Centre National De La Recherche Scientifique (Cnrs) Functionalization of gold nanoparticles with oriented proteins. application to the high-density labelling of cell membranes
WO2009136741A1 (en) * 2008-05-07 2009-11-12 Seoul National University Industry Foundation Novel au / ag core-shell composite useful for biosensor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Krueger A et al., "Functionality is Key: Recent Progress in the Surface Modification of Nanodiamond", Advanced Functional Materials, vol.22, no.5, p.890-906, 2012/01/16 *

Also Published As

Publication number Publication date
TW201335374A (en) 2013-09-01

Similar Documents

Publication Publication Date Title
Zhao et al. In situ synthesis of fluorescent mesoporous silica–carbon dot nanohybrids featuring folate receptor-overexpressing cancer cell targeting and drug delivery
Hu et al. Facile synthesis of red dual-emissive carbon dots for ratiometric fluorescence sensing and cellular imaging
Wei et al. In situ crystal growth of gold nanocrystals on upconversion nanoparticles for synergistic chemo-photothermal therapy
Yang et al. Ultrasmall and photostable nanotheranostic agents based on carbon quantum dots passivated with polyamine-containing organosilane molecules
Ganeshkumar et al. Green synthesis of pullulan stabilized gold nanoparticles for cancer targeted drug delivery
Siddiquee et al. Green synthesis of silver nanoparticles from Delonix regia leaf extracts: In-vitro cytotoxicity and interaction studies with bovine serum albumin
Ruiyi et al. Graphene quantum dot-rare earth upconversion nanocages with extremely high efficiency of upconversion luminescence, stability and drug loading towards controlled delivery and cancer theranostics
Szczeszak et al. Spectroscopic, structural and in vitro cytotoxicity evaluation of luminescent, lanthanide doped core@ shell nanomaterials GdVO4: Eu3+ 5%@ SiO2@ NH2
Zhang et al. Perylenediimide chromophore as an efficient photothermal agent for cancer therapy
Vishnevetskii et al. l-Cysteine as a reducing/capping/gel-forming agent for the preparation of silver nanoparticle composites with anticancer properties
Zhang et al. Spore-derived color-tunable multi-doped carbon nanodots as sensitive nanosensors and intracellular imaging agents
Zhao et al. One-step synthesis of fluorescent organic nanoparticles: The application to label-free ratiometric fluorescent pH sensor
Xu et al. Bioresponsive upconversion nanostructure for combinatorial bioimaging and chemo-photothermal synergistic therapy
Mancic et al. NIR photo-driven upconversion in NaYF4: Yb, Er/PLGA particles for in vitro bioimaging of cancer cells
Li et al. Green and facile synthesis of l-carnosine protected fluorescent gold nanoclusters for cellular imaging
Sonthanasamy et al. Surface functionalization of highly luminescent carbon nanodots from Dioscorea hispida with polyethylene glycol and branched polyethyleneimine and their in vitro study
Chakraborty et al. Effects of protecting groups on luminescent metal nanoclusters: spectroscopic signatures and applications
Lian et al. Synthesis of highly stable cyanine-dye-doped silica nanoparticle for biological applications
Wei et al. Supramolecules‐Guided Synthesis of Brightly Near‐Infrared Au22 Nanoclusters with Aggregation‐Induced Emission for Bioimaging
Hou et al. ATP fluorescent nanoprobe based on ZIF-90 and near-infrared dyes for imaging in tumor mice
Slegerova et al. Nanodiamonds as intracellular probes for imaging in biology and medicine
Li et al. Photothermal sensor based on water-soluble CsPbBr3@ sulfobutylether-β-cyclodextrins nanocomposite using a thermometer as readout
Mutti et al. Design of a red-emitter hybrid material for bioimaging: europium complexes grafted on silica particles
Wang et al. Self-dispersible fluorescent probe with aggregation-induced emission feature for sequence detection of Fe3+ and Ca2+
Chen et al. Noninvasive near-infrared light triggers the remote activation of thermo-responsive TRPV1 channels in neurons based on biodegradable/photothermal polymer micelles